Currently holds positions in Novocure Ltd, OptiNose Inc and Minerva Neurosciences Inc
Position | Company | Period |
---|---|---|
Executive Chairman of the Board | Novocure Ltd | May 11, 2016 - |
Independent Director | OptiNose Inc | Jan. 1, 2010 - |
Lead Independent Director | Minerva Neurosciences Inc | Feb. 5, 2018 - |
Director | Minerva Neurosciences Inc | Dec. 11, 2017 - Feb. 5, 2018 |
Independent Director | Zoetis Inc | Feb. 3, 2015 - May 12, 2016 |
Chairman of the Board | Novocure Ltd | Jan. 1, 2004 - May 11, 2016 |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2024-03-12 | 2024-03-08 |
Elanco Animal Health Inc
(ELAN)
|
B Purchase |
15,000
+32.4%
16.30244,500 USD |
15,000 +32.4% | 16.30 | 244,500 USD | |
2022-08-03 | 2022-08-02 |
Novocure Ltd
(NVCR)
|
S Sale |
837
-0.2%
69.6658,305 USD |
837 -0.2% | 69.66 | 58,305 USD | |
2022-03-09 | 2022-03-08 |
Novocure Ltd
(NVCR)
|
S Sale |
2,385
-0.4%
70.10167,189 USD |
2,385 -0.4% | 70.10 | 167,189 USD | |
2021-04-15 | 2021-04-13 |
Novocure Ltd
(NVCR)
|
PS Planned sale |
600
-0.1%
216.69130,016 USD |
600 -0.1% | 216.69 | 130,016 USD | |
2021-04-15 | 2021-04-13 |
Novocure Ltd
(NVCR)
|
PS Planned sale |
500
-0.1%
214.67107,333 USD |
500 -0.1% | 214.67 | 107,333 USD | |
2021-04-15 | 2021-04-13 |
Novocure Ltd
(NVCR)
|
PS Planned sale |
1,500
-0.3%
213.35320,021 USD |
1,500 -0.3% | 213.35 | 320,021 USD | |
2021-04-15 | 2021-04-13 |
Novocure Ltd
(NVCR)
|
PS Planned sale |
600
-0.1%
211.28126,766 USD |
600 -0.1% | 211.28 | 126,766 USD | |
2021-04-15 | 2021-04-13 |
Novocure Ltd
(NVCR)
|
PS Planned sale |
521
-0.1%
210.18109,504 USD |
521 -0.1% | 210.18 | 109,504 USD | |
2021-04-15 | 2021-04-13 |
Novocure Ltd
(NVCR)
|
PS Planned sale |
2,200
-0.4%
209.34460,555 USD |
2,200 -0.4% | 209.34 | 460,555 USD | |
2021-04-15 | 2021-04-13 |
Novocure Ltd
(NVCR)
|
PS Planned sale |
4,500
-0.8%
207.80935,118 USD |
4,500 -0.8% | 207.80 | 935,118 USD | |
2021-04-15 | 2021-04-13 |
Novocure Ltd
(NVCR)
|
PS Planned sale |
1,284
-0.2%
206.35264,956 USD |
1,284 -0.2% | 206.35 | 264,956 USD | |
2021-04-15 | 2021-04-13 |
Novocure Ltd
(NVCR)
|
PS Planned sale |
1,600
-0.3%
205.43328,690 USD |
1,600 -0.3% | 205.43 | 328,690 USD | |
2021-04-15 | 2021-04-13 |
Novocure Ltd
(NVCR)
|
PS Planned sale |
1,972
-0.3%
204.28402,834 USD |
1,972 -0.3% | 204.28 | 402,834 USD | |
2021-04-15 | 2021-04-13 |
Novocure Ltd
(NVCR)
|
PS Planned sale |
2,555
-0.4%
203.25519,311 USD |
2,555 -0.4% | 203.25 | 519,311 USD | |
2021-04-15 | 2021-04-13 |
Novocure Ltd
(NVCR)
|
PS Planned sale |
4,388
-0.8%
202.16887,069 USD |
4,388 -0.8% | 202.16 | 887,069 USD | |
2021-04-15 | 2021-04-13 |
Novocure Ltd
(NVCR)
|
PS Planned sale |
4,125
-0.7%
201.55831,377 USD |
4,125 -0.7% | 201.55 | 831,377 USD | |
2021-04-15 | 2021-04-13 |
Novocure Ltd
(NVCR)
|
PS Planned sale |
4,338
-0.7%
199.71866,355 USD |
4,338 -0.7% | 199.71 | 866,355 USD | |
2021-04-15 | 2021-04-13 |
Novocure Ltd
(NVCR)
|
PS Planned sale |
10,563
-1.8%
198.982,101,794 USD |
10,563 -1.8% | 198.98 | 2,101,794 USD | |
2021-04-15 | 2021-04-13 |
Novocure Ltd
(NVCR)
|
PS Planned sale |
13,612
-2.2%
197.832,692,876 USD |
13,612 -2.2% | 197.83 | 2,692,876 USD | |
2021-04-15 | 2021-04-13 |
Novocure Ltd
(NVCR)
|
PS Planned sale |
24,338
-3.8%
197.004,794,659 USD |
24,338 -3.8% | 197.00 | 4,794,659 USD | |
2021-04-15 | 2021-04-13 |
Novocure Ltd
(NVCR)
|
PS Planned sale |
8,814
-1.4%
196.071,728,187 USD |
8,814 -1.4% | 196.07 | 1,728,187 USD | |
2021-04-15 | 2021-04-13 |
Novocure Ltd
(NVCR)
|
PS Planned sale |
1,600
-0.2%
194.94311,904 USD |
1,600 -0.2% | 194.94 | 311,904 USD | |
2021-04-15 | 2021-04-13 |
Novocure Ltd
(NVCR)
|
PS Planned sale |
2,090
-0.3%
193.57404,563 USD |
2,090 -0.3% | 193.57 | 404,563 USD | |
2021-04-15 | 2021-04-13 |
Novocure Ltd
(NVCR)
|
PS Planned sale |
1,900
-0.3%
192.52365,796 USD |
1,900 -0.3% | 192.52 | 365,796 USD | |
2021-04-15 | 2021-04-13 |
Novocure Ltd
(NVCR)
|
PS Planned sale |
1,400
-0.2%
191.26267,768 USD |
1,400 -0.2% | 191.26 | 267,768 USD | |
2021-04-02 | 2021-04-01 |
Novocure Ltd
(NVCR)
|
S Sale |
7,928
-1.2%
134.121,063,303 USD |
7,928 -1.2% | 134.12 | 1,063,303 USD | |
2020-08-03 | 2020-07-31 |
Novocure Ltd
(NVCR)
|
S Sale |
896
-0.1%
76.3968,444 USD |
896 -0.1% | 76.39 | 68,444 USD | |
2020-05-12 | 2020-05-11 |
Novocure Ltd
(NVCR)
|
S Sale |
31,332
-4.6%
63.731,996,726 USD |
31,332 -4.6% | 63.73 | 1,996,726 USD | |
2020-05-11 | 2020-05-08 |
Novocure Ltd
(NVCR)
|
S Sale |
31,903
-4.5%
63.502,025,872 USD |
31,903 -4.5% | 63.50 | 2,025,872 USD | |
2020-05-11 | 2020-05-07 |
Novocure Ltd
(NVCR)
|
S Sale |
30,993
-4.5%
64.742,006,518 USD |
30,993 -4.5% | 64.74 | 2,006,518 USD | |
2020-05-07 | 2020-05-06 |
Novocure Ltd
(NVCR)
|
S Sale |
29,881
-5.0%
64.271,920,452 USD |
29,881 -5.0% | 64.27 | 1,920,452 USD | |
2020-05-07 | 2020-05-05 |
Novocure Ltd
(NVCR)
|
S Sale |
30,283
-4.8%
62.471,891,718 USD |
30,283 -4.8% | 62.47 | 1,891,718 USD | |
2020-03-10 | 2020-03-06 |
Novocure Ltd
(NVCR)
|
S Sale |
4,320
-0.8%
69.53300,387 USD |
4,320 -0.8% | 69.53 | 300,387 USD | |
2020-03-02 | 2020-02-28 |
Novocure Ltd
(NVCR)
|
S Sale |
3,893
-0.8%
72.22281,133 USD |
3,893 -0.8% | 72.22 | 281,133 USD | |
2020-01-22 | 2020-01-17 |
Novocure Ltd
(NVCR)
|
PS Planned sale |
133,777
-20.8%
95.0012,708,815 USD |
133,777 -20.8% | 95.00 | 12,708,815 USD | |
2019-07-01 | 2019-06-27 |
Minerva Neurosciences Inc
(NERV)
|
B Purchase |
3,500
+15.5%
5.5019,250 USD |
3,500 +15.5% | 5.50 | 19,250 USD | |
2019-06-03 | 2019-05-30 |
Novocure Ltd
(NVCR)
|
S Sale |
48,100
-5.4%
53.072,552,523 USD |
48,100 -5.4% | 53.07 | 2,552,523 USD | |
2019-05-31 | 2019-05-29 |
Novocure Ltd
(NVCR)
|
S Sale |
1,900
-0.2%
53.10100,881 USD |
1,900 -0.2% | 53.10 | 100,881 USD | |
2019-05-10 | 2019-05-09 |
Novocure Ltd
(NVCR)
|
S Sale |
31,460
-3.4%
47.371,490,386 USD |
31,460 -3.4% | 47.37 | 1,490,386 USD | |
2019-05-09 | 2019-05-08 |
Novocure Ltd
(NVCR)
|
S Sale |
32,218
-3.6%
47.521,531,032 USD |
32,218 -3.6% | 47.52 | 1,531,032 USD | |
2019-05-09 | 2019-05-07 |
Novocure Ltd
(NVCR)
|
S Sale |
32,098
-3.7%
47.671,530,112 USD |
32,098 -3.7% | 47.67 | 1,530,112 USD | |
2019-05-07 | 2019-05-06 |
Novocure Ltd
(NVCR)
|
S Sale |
29,038
-3.4%
48.071,395,915 USD |
29,038 -3.4% | 48.07 | 1,395,915 USD | |
2019-05-06 | 2019-05-03 |
Novocure Ltd
(NVCR)
|
S Sale |
29,966
-3.7%
45.211,354,643 USD |
29,966 -3.7% | 45.21 | 1,354,643 USD | |
2019-03-01 | 2019-02-28 |
Novocure Ltd
(NVCR)
|
S Sale |
3,097
-0.3%
53.68166,247 USD |
3,097 -0.3% | 53.68 | 166,247 USD | |
2018-12-26 | 2018-12-20 |
Minerva Neurosciences Inc
(NERV)
|
B Purchase |
2,000
+9.7%
6.5013,000 USD |
2,000 +9.7% | 6.50 | 13,000 USD | |
2018-12-12 | 2018-12-11 |
Minerva Neurosciences Inc
(NERV)
|
B Purchase |
4,000
+24.1%
7.9531,800 USD |
4,000 +24.1% | 7.95 | 31,800 USD | |
2018-12-12 | 2018-12-10 |
Minerva Neurosciences Inc
(NERV)
|
B Purchase |
2,000
+13.7%
8.0016,000 USD |
2,000 +13.7% | 8.00 | 16,000 USD | |
2018-11-21 | 2018-11-20 |
Minerva Neurosciences Inc
(NERV)
|
B Purchase |
2,000
+15.9%
8.2016,400 USD |
2,000 +15.9% | 8.20 | 16,400 USD | |
2018-10-15 | 2018-10-11 |
Minerva Neurosciences Inc
(NERV)
|
B Purchase |
600
+5.0%
10.006,000 USD |
600 +5.0% | 10.00 | 6,000 USD | |
2018-09-19 | 2018-09-17 |
Minerva Neurosciences Inc
(NERV)
|
B Purchase |
1,800
+17.6%
10.5018,900 USD |
1,800 +17.6% | 10.50 | 18,900 USD | |
2018-09-17 | 2018-09-14 |
Minerva Neurosciences Inc
(NERV)
|
B Purchase |
200
+2.0%
10.502,100 USD |
200 +2.0% | 10.50 | 2,100 USD | |
2018-09-17 | 2018-09-13 |
Minerva Neurosciences Inc
(NERV)
|
B Purchase |
2,000
+25.0%
10.5021,000 USD |
2,000 +25.0% | 10.50 | 21,000 USD | |
2018-09-11 | 2018-09-11 |
Minerva Neurosciences Inc
(NERV)
|
B Purchase |
4,011
+100.3%
9.7238,987 USD |
4,011 +100.3% | 9.72 | 38,987 USD | |
2018-09-11 | 2018-09-10 |
Minerva Neurosciences Inc
(NERV)
|
B Purchase |
4,000
+inf%
9.8839,520 USD |
4,000 +inf% | 9.88 | 39,520 USD |